| 000 | 01770 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513140630.0 | ||
| 264 | 0 | _c19980513 | |
| 008 | 199805s 0 0 eng d | ||
| 022 | _a0167-594X | ||
| 024 | 7 |
_a10.1023/a:1005867520788 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHellman, R | |
| 245 | 0 | 0 |
_aA therapeutic trial of radiation therapy with Vincristine, etoposide, and Procarbazine (VVP) in high grade intracranial gliomas--an Eastern Cooperative Oncology Group Study (E2392). _h[electronic resource] |
| 260 |
_bJournal of neuro-oncology _cMar 1998 |
||
| 300 |
_a55-62 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aAstrocytoma _xdrug therapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlioblastoma _xdrug therapy |
| 650 | 0 | 4 |
_aGlioma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProcarbazine _xadministration & dosage |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aNeuberg, D S | |
| 700 | 1 | _aWagner, H | |
| 700 | 1 | _aGrunnet, M | |
| 700 | 1 | _aRobins, H I | |
| 700 | 1 | _aKarp, D | |
| 700 | 1 | _aFlynn, P | |
| 700 | 1 | _aAdams, G | |
| 773 | 0 |
_tJournal of neuro-oncology _gvol. 37 _gno. 1 _gp. 55-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1005867520788 _zAvailable from publisher's website |
| 999 |
_c9493480 _d9493480 |
||